Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
January
24
DNA tests show that mystery inflammatory syndrome may not be so rare
Geneseeq nabs CE Marks for minimal residual disease, early cancer detection tests
Metabolon closes $25M in equity financing
Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies
Geneoscopy applies for FDA approval of at-home CRC screening test
Thermo Fisher Scientific, AstraZeneca to develop solid tissue and blood-based CDx for NSCLC
Page 1 of 1